As medical trainees, we are all familiar with the match process. It proceeds in a predictable way: talk to mentors, submit your CV, receive interview invitations, attend interviews, rank your choices and cross your fingers. All steps are completed within a pre-specified period of time and with a clearly defined process in place. Transitioning from…
Want to know which drugs could soon compete with Wegovy or Mounjaro? The STAT Obesity Drug Tracker is following dozens of candidates.
Blending together the highly diverse pool of Asian Americans in widely used metrics obscures vast differences in their health.
A STAT investigation found artificial intelligence is driving Medicare Advantage denials to new heights, cutting off care for seniors.
Our mission is to empower patients with heart failure by eliminating financial barriers and making life-saving heart transplants accessible.
A STAT investigation found artificial intelligence is driving Medicare Advantage denials to new heights, cutting off care for seniors.
Want to know which drugs could soon compete with Wegovy or Mounjaro? The STAT Obesity Drug Tracker is following dozens of candidates.
The National Institute for Occupational Safety and Health’s (NIOSH) Impact Wellbeing ™ campaign gives hospital leaders evidence-informed solutions to reduce healthcare worker burnout, sustain wellbeing,…
The FDA gave feedback on a nonprofit group’s proposal for a phase III clinical trial focused on estradiol as a gender-affirming treatment for trans and…
Weight gain is one of the most common concerns among women going through menopause. New drugs could change that.
A White House Domestic Policy Council deputy criticized Bristol-Myers Squibb’s efforts to fight off generic competition for a popular blood thinner.
